Active site characteristics of CYP4B1 probed with aromatic ligands

被引:22
|
作者
Henne, KR [1 ]
Fisher, MB [1 ]
Iyer, KR [1 ]
Lang, DH [1 ]
Trager, WF [1 ]
Rettie, AE [1 ]
机构
[1] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA
关键词
D O I
10.1021/bi010395e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The active site topography of rabbit CYP4B1 has been studied relative to CYP2B1 and CYP102 using a variety of aromatic probe substrates. Oxidation of the prochiral substrate cumene by CYP4B1, but not CYP2B1 or CYP102, resulted in the formation of the thermodynamically disfavored omega -hydroxy metabolite, 2-phenyl-1-propanol, with product stereoselectivity for the (S)-enantiomer. Reaction of CYP4B1, CYP2B1, and CYP102 with phenyldiazene produced spectroscopically observable sigma -complexes for each enzyme. Subsequent oxidation of the CYP2B1 and CYP102 complexes followed by LC/ESI-MS analysis yielded heme pyrrole migration patterns similar to those in previous literature reports. Upon identical treatment, no migration products were detected for CYP4B1. Intramolecular deuterium isotope effects for the benzylic hydroxylation of o-xylene-alpha-H-2(3), p-xylene-alpha-H-2(3), 2-H-2(3),6-dimethylnaphthalene, and 4-H-2(3),4'-dimethylbiphenyl were determined for CYP4B1 and CYP2B1 to further map their active site dimensions. These probes permit assessment of the ease of equilibration, within P450 active sites, of oxidizable methyl groups located between 3 and 10 Angstrom apart [Iyer et al. (1997) Biochemistry 36, 7136-7143]. Isotope effects for the CYP4B1-mediated benzylic hydroxylation of o- and p-xylenes were fully expressed (k(H)/k(D) = 9.7 and 6.8, respectively), whereas deuterium isotope effects for the naphthyl and biphenyl derivatives were both substantially masked (k(H)/k(D) approximate to 1) In contrast, significant suppression of the deuterium isotope effects for CYP2B1 occurred only with the biphenyl substrate. Therefore, rapid equilibration between two methyl groups more than 6 Angstrom apart is impeded within the active site of CYP4B1, whereas for CYP2B1, equilibration is facile for methyl groups distanced by more than 8 Angstrom. Collectively, all data are consistent with the conclusion that the active site of CYP4B1 is considerably restricted relative to CYP2B1.
引用
收藏
页码:8597 / 8605
页数:9
相关论文
共 50 条
  • [1] Spotlight on CYP4B1
    Roeder, Annika
    Huesken, Saskia
    Hutter, Michael C.
    Rettie, Allan E.
    Hanenberg, Helmut
    Wiek, Constanze
    Girhard, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [2] Generation and Characterization of a Cyp4b1 Null Mouse and the Role of CYP4B1 in the Activation and Toxicity of Ipomeanol
    Parkinson, Oliver T.
    Liggitt, H. Denny
    Rettie, Allan E.
    Kelly, Edward J.
    TOXICOLOGICAL SCIENCES, 2013, 134 (02) : 243 - 250
  • [3] TCDD suppresses the expression of CYP4B1
    Zhang, L
    Dingle, RWC
    Xu, P
    Swanson, HI
    PROCEEDINGS OF THE 14TH INTERNATIONAL CONFERENCE ON CYTOCHROMES P450: BIOCHEMISTRY, BIOPHYSICS, AND BIOINFORMATICS, 2005, : 137 - 143
  • [4] Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution
    Schmidt, Eva M.
    Wiek, Constanze
    Parkinson, Oliver T.
    Roellecke, Katharina
    Freund, Marcel
    Gombert, Michael
    Lottmann, Nadine
    Steward, Charles A.
    Kramm, Christof M.
    Yarov-Yarovoy, Vladimir
    Rettie, Allan E.
    Hanenberg, Helmut
    PLOS ONE, 2015, 10 (09):
  • [5] CYP4B1 ACTIVATES 4-IPOMEANOL IN RAT LUNG
    VERSCHOYLE, RD
    PHILPOT, RM
    WOLF, CR
    DINSDALE, D
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 123 (02) : 193 - 198
  • [6] CYP4B1 AS A NOVEL SUICIDE GENE IN CANCER THERAPY
    Hanenberg, Helmut
    Roellecke, Katharina
    Wiek, Constanze
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S8 - S9
  • [7] A transgenic mouse expressing human CYP4B1 in the liver
    Imaoka, S
    Hayashi, K
    Hiroi, T
    Yabusaki, Y
    Kamataki, T
    Funae, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (03) : 757 - 762
  • [8] MUTAGENIC ACTIVATION OF 3-METHOXY-4-AMINOAZOBENZENE BY MOUSE RENAL CYTOCHROME-P450 CYP4B1 - CLONING AND CHARACTERIZATION OF MOUSE CYP4B1
    IMAOKA, S
    HIROI, T
    TAMURA, Y
    YAMAZAKI, H
    SHIMADA, T
    KOMORI, N
    DEGAWA, M
    FUNAE, Y
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 321 (01) : 255 - 262
  • [9] Lung-selective regulation of CYP2F1 and CYP4B1
    Yost, GS
    DRUG METABOLISM REVIEWS, 2002, 34 : 24 - 24
  • [10] CYP4B1:: Expression in urothelial cells, polymorphism and bladder cancer
    Roos, PH
    Dörrenhaus, A
    Roth, G
    Seidel, T
    Dietrich, H
    Golka, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 131 - 131